Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,69
PKN64,5564,58-0,55
Msft444,06444,12-1,21
Nokia3,53,59951,69
IBM186,97187,040,65
Mercedes-Benz Group AG63,2363,25-0,31
PFE29,9629,971,58
17.07.2024 20:18:51
Indexy online
AD Index online
select
AD Index online
 

  • 17.07.2024 20:17:52
Quest Diagnostcs (DGX, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
149,10 0,33 0,50 358 583
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 17.07.2024
Popis společnosti
Obecné informace
Název společnostiQuest Diagnostics Inc
TickerDGX
Kmenové akcie:Ordinary Shares
RICDGX
ISIN-
Prioritní akciePreference Shares
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.03.2024
Počet zaměstnanců k 31.12.2023 40 000
Akcie v oběhu k 15.04.2024 111 091 574
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice500 Plaza Drive
MěstoSECAUCUS
PSČ07094
ZeměUnited States
Kontatní osobaShawn Bevec
Funkce kontaktní osobyVice President - Investor Relations
Telefon19 735 202 700
Fax13026555049
Kontatní telefon19 735 202 900

Business Summary: Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The Company also focuses on artificial intelligence (AI) and digital pathology solutions for biopharmaceutical companies and pathology laboratories. It has implemented AI, digital and automation technologies across several laboratory and business functions.
Financial Summary: BRIEF: For the three months ended 31 March 2024, Quest Diagnostics Inc revenues increased 2% to $2.37B. Net income applicable to common stockholders decreased 4% to $193M. Revenues reflect Diagnostic Information Services Business segment increase of 2% to $2.3B. Net income was offset by General corporate activities segment loss increase of 6% to $82M, Diagnostic Information Services Business segment income decrease of less than 1% to $373M.
Odvětvová klasifikace
TRBC2009Healthcare Facilities / Services
TRBC2012Healthcare Facilities & Services (NEC)
RBSS2004Healthcare Facilities
MGINDUSTRYHealthcare Facilities
MGSECTORHealthcare
NAICSMedical Laboratories
NAICS2007Medical Laboratories
NAICS1997Medical Laboratories
SICMedical Laboratories
SICMedical Laboratories



  • Poslední aktualizace: 17.07.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Executive Chairman of the Board, President, Chief Executive OfficerJames Davis6101.04.202316.04.2013
Chief Financial Officer, Executive Vice PresidentSam Samad5425.07.202211.07.2022
Senior Vice President, Chief Information and Digital OfficerMurali Balakumar-06.05.202406.05.2024
Senior Vice President, General CounselMichael Prevoznik62
Senior Vice President, Chief Commercial OfficerMark Delaney5620.04.202220.04.2022
Senior Vice President - Regional BusinessesCatherine Doherty6120.04.2022
Senior Vice President - Molecular Genomics & OncologyMark Gardner58
Senior Vice President - Clinical SolutionsKarthik Kuppusamy54
Senior Vice President - Diagnostic ServicesPatrick Plewman5720.04.202220.04.2022